Patent 7459461 was granted and assigned to Ortho-McNeil Pharmaceutical on December, 2008 by the United States Patent and Trademark Office.
The present invention is directed to phosphonic acid compounds useful as serine protease inhibitors, compositions thereof and methods for treating inflammatory and serine protease mediated disorders.